Home  >  TopNews
Disease Profile
+ Font Resize -

UK healthcare cos discuss collaborations with Indian healthcare institutions to further cancer care

Our Bureau, Mumbai
Saturday, November 18, 2017, 08:00 Hrs  [IST]

There is a greater challenge of non-communicable diseases (NCDs) like cancer and diabetes in India compounded further with the burgeoning requirement of one million beds. Added to it is the challenge of shortage of doctors, allied health professionals and paramedics.

These were the thoughts shared at the UK’s Department for International Trade delegation event which saw participation of twelve of the most innovative healthcare companies specialising in Oncology in Mumbai recently. Indian companies got an opportunity to network with UK healthcare firms and explored opportunities for collaboration during the event.

The Mumbai forum was jointly organised by the Department for International Trade, British Deputy High Commission, Mumbai in collaboration with Confederation of Indian Industry (CII). The delegation was in Bengaluru from 9-12 November to attend the 2nd Indian Cancer Congress.  

Crispin Simon, British Deputy High Commissioner, Western India and Director General of Department for International Trade, India & South Asia said: “The UK has a clear focus to transform healthcare service delivery through integrated healthcare systems, emergency and acute medicine in and out of hospital. With an unmatched combination of clinical, technological and academic expertise, the UK is ideally placed to play a significant role in working with India in the transformation of its healthcare goals. I hope that through our delegation, we will help build some ground-breaking partnerships in overcoming the specific healthcare challenge in India.

“We are also helping Indian businesses access the best of advanced British technology in healthcare by taking Indian delegations across the UK as a part of the India-UK Future TECH month. This is a very good platform for both the UK and India to work together for improved healthcare in India.”

India is expected to see 1.45 million new cases of cancer in 2016 rising to 1.73 million new cases by 2020 (National Cancer Registry). Oral, breast, lung, cervical cancers are among the leading causes of deaths in India.

“The need can be further be realised as there is a patient load of nearly 80% alone at Mumbai’s Tata Memorial Hospital which caters to cancer patients from across the country,” said Dr Pravin Shingare, director, Directorate of Medical Education and Research (DMER).

India requires new technology in every aspect of this disease be it prediction through genetics, early detection, new treatment protocols and medical equipment. There is no greater collective threat to the health of our citizens than that posed by long term conditions such as Cancer.

India and the UK share common goals in this regard. The UK is at the forefront of cancer research, as well as the development and introduction of new technologies. The NHS has a cancer strategy to improve cancer prevention, diagnosis, treatment and end-of-life care.

The NHS and UK companies have compelling offers in cancer for overseas health systems covering advanced laboratory diagnostics including the latest genomic testing, provision of leading edge cancer services, development of the latest clinical protocols to achieve high quality clinical outcomes, R&D collaborations with potential for longer term partnerships in specific clinical areas, unmatched data assets to underpin research and the full range of education and training in cancer for doctors, nurses and technical staff.

Conclusively, UK has an unmatched combination of clinical, technological and academic expertise.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
PITS_2017
duphat_150x60
Pre-Connect Congress 2017
acssymposium
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |